Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2008-12-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At present, it is unknown whether this concept can be extended to use by parents when administering paracetamol to their children at home.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The British National Formulary for Children (BNFC), introduced in 2005, has given hospital and community prescribers with a valuable reference text.
However, the comprehensive prescribing information presented in the BNFC and in the drug Summary of Product Characteristics is simplified in the Patient Information Leaflet (PIL) for interpretation by parents. When the PIL is analysed, it becomes apparent that the age-range regimens presented may result in under and over-dosing with large differences in the daily dose received by children depending on their age and weight.
The Paediatric Analgesia Slide is a simple device presenting pre-calculated volume (and therefore dose) information for parents. It allows for age/weight specific doses to be given thus minimising the risk of under and over-dosing. It also addresses the deficiency of the prescribing information in the PIL related to over and under-weight children.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Using the information distributed with over-the-counter medication (The Patient Information Leaflet or PIL)
No interventions assigned to this group
2
Paediatric Analgesia Slide (the new device)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those who already have been given advice on the correct dose of paracetamol for their child as part of the current hospital episode;
* Those who's child is under 1 year or over 13 years old and;
* Those who have participated in this research before.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
County Durham and Darlington NHS Foundation Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
County Durham and Darlington NHS Foundation Trust
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard C Hixson, BM BS, FRCA
Role: PRINCIPAL_INVESTIGATOR
County Durham and Darlington Acute Hospitals NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
County Durham and Darlington Acute Hospitals NHS Trust
Darlington, England, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Richard C Hixson, BM BS FRCA
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08/H0904/93
Identifier Type: -
Identifier Source: org_study_id